Detection of Cytochrome P450 Polymorphisms in Breast Cancer Patients May Impact on Tamoxifen Therapy

BACKGROUND: Breast cancer is the most common cancer among women worldwide. Tamoxifen (TAM), a selective estrogen receptor modulator, is widely used in its treatment. TAM is metabolized by cytochrome P450 (CYP450) enzymes, including CYP2D6, CYP3A5 and CYP2C19, whose genetic variations may have clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Thota, Kanakaiah, Prasad, K, Rao, Mandava V Basaveswara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980918/
https://www.ncbi.nlm.nih.gov/pubmed/29479969
http://dx.doi.org/10.22034/APJCP.2018.19.2.343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980918/
https://www.ncbi.nlm.nih.gov/pubmed/29479969
http://dx.doi.org/10.22034/APJCP.2018.19.2.343

Ejemplares similares